| Inde | Turquie | Espagne | |
| Radiothérapie pour le cancer colorectal | de $3,200 | de $7,000 | de $10,000 |
| Radiochirurgie stéréotaxique | de $5,200 | de $4,500 | de $12,000 |
| Craniotomie | de $5,733 | de $5,650 | de $25,000 |
| Chimiothérapie pour le cancer du sein | de $3,500 | de $1,200 | de $3,500 |
Bookimed ne rajoute pas de frais pour les traitements de Médulloblastome. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Médulloblastome et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Médulloblastome.
Le Dr Sridhar est spécialisé en radiothérapie pour les tumeurs cérébrales complexes au HCG Manavata Cancer Centre.
Plus de 30 000 TEP-scanners réalisés et 1 000 patients atteints de cancer de la thyroïde pris en charge – Le Dr Borde apporte une vaste expertise en médecine nucléaire aux cas de médulloblastome.
Le Dr Shruti Kate est spécialisée dans les tumeurs pédiatriques, y compris le médulloblastome, avec une formation au Tata Memorial Hospital – l'un des principaux centres de cancérologie de l'Inde.
Medulloblastoma treatment in India follows multi-modal protocols including maximal safe surgical resection, risk-stratified craniospinal irradiation, and systemic chemotherapy. Indian centers utilize advanced Volumetric Modulated Arc Therapy and Proton Beam Therapy. Treatment intensity is adjusted based on age, tumor residual, and molecular subtyping.
Bookimed Expert Insight: Quality of care in India is concentrated in high-volume oncology clusters like Chennai and Gurgaon. Clinics such as Global Hospital Chennai and Fortis Gurgaon utilize linear accelerators with 1 mm accuracy. These facilities serve up to 80,000 patients annually. This high volume ensures surgeons maintain the precision required for complex posterior fossa resections.
Patient Consensus: Patients emphasize the need for large tertiary cancer centers over smaller hospitals for this complex surgery. They note that long-term follow-up must include regular hearing checks and neurodevelopment monitoring.
Indian specialists achieve cure rates of 70% to 85% for standard-risk medulloblastoma in children. Success depends on early diagnosis and complete surgical removal. Major centers in India follow international neuro-oncology protocols. These combine precision neurosurgery, craniospinal radiation, and intensive chemotherapy.
Bookimed Expert Insight: India has become a global hub for neuro-oncology because it offers high-volume clinical expertise at facilities like HCG Manavata Cancer Centre. This clinic has treated over 100,000 patients and maintains a staff of 40+ oncologists. For medulloblastoma, success is linked to the surgeon’s experience. Dr. Raj Nagarkar has performed over 50,000 surgeries, showing the deep technical skill available in Indian specialized centers.
Patient Consensus: Patients emphasize that receiving a second opinion is vital to confirm risk stratification. They often highlight that while treatment is effective, focusing on long-term rehabilitation for side effects like fatigue is necessary.
Medulloblastoma treatment risks include neurological deficits from surgery, hearing loss from chemotherapy, and hormonal imbalances after radiation. Long-term side effects often manifest as cognitive delays, growth deficiencies, and impaired coordination. Specialized Indian centers utilize linear accelerators with 1mm accuracy to minimize damage to healthy brain tissue.
Bookimed Expert Insight: Coordination of care is the most critical factor for long-term outcomes in India. Top-tier facilities like Global Hospital Chennai and HCG Manavata Cancer Centre integrate pediatric oncology with specialized audiology and endocrinology. Choosing a center with these built-in support services ensures early detection of late effects like hearing loss or growth hormone deficiency without needing separate referrals.
Patient Consensus: Patients note it is vital to request baseline hearing tests before starting chemotherapy and to emphasize fertility preservation early. Families frequently highlight that daily stamina and school performance may lag even when follow-up scans show clear results.
Medical centers in Chennai, Gurgaon, Mumbai, and Bengaluru offer high-level expertise for medulloblastoma treatment. These hubs feature specialized pediatric tumor boards and advanced neuro-navigation. Facilities like Apollo Proton Cancer Centre and HCG Cancer Hospital provide precision radiation essential for protecting developing tissues.
Bookimed Expert Insight: Patient volume data often reveals hidden specializations. While many associate Gurgaon with adult transplants, Medanta manages 20,000 patients annually with a heavy focus on complex neuro-oncology imaging. For pediatric cases, choosing a facility like HCG Manavata, which manages 75,000 patients yearly, ensures access to doctors like Dr. Shruti Kate who have specific training from India's apex cancer institutes.
Patient Consensus: Families emphasize finding a hospital that coordinates surgery, radiation, and chemotherapy in one location. Many recommend getting a second pathology opinion from major metro centers to confirm the specific tumor subtype before starting treatment.
International families should plan a stay of 7 to 10 months for complete medulloblastoma treatment in India. This duration covers surgery, craniospinal radiation, and maintenance chemotherapy. Families can reduce this stay to approximately 3 months by completing the final chemotherapy phase in their home country.
Bookimed Expert Insight: Choosing centers with integrated research and high patient volumes, such as HCG Manavata Cancer Centre which serves 75,000 patients annually, ensures access to specialists like Dr. Shruti Kate who have specific pediatric oncology training. High-volume Indian centers often provide more stable scheduling for complex, multi-phase treatments which helps prevent delays in the 7-month timeline.
Patient Consensus: Families emphasize that the stay is a marathon rather than a sprint, often requiring a `just in case` time cushion for neurologic assessments and pathology reviews. Most suggest booking furnished apartments with kitchens because preparing hygienic, home-cooked meals is vital for children during long chemotherapy cycles.